Articles

  • 1 week ago | clinicalleader.com | Miranda McLaren

    By Miranda McLarenExplore the transformative potential of community-based research sites in clinical trials, particularly in enhancing patient experiences and fostering diversity. Traditional trial models often struggle to recruit minority populations due to logistical barriers, but community-based approaches significantly improve accessibility and engagement.

  • 1 week ago | clinicalleader.com | Miranda McLaren

    By Miranda McLarenThe obesity drug development landscape is rapidly evolving, driven by the World Health Organization's recognition of obesity as a critical public health problem. With projections indicating over 161.5 million cases in major pharmaceutical markets by 2033, the demand for effective treatments is surging.

  • 1 week ago | clinicaltrialsarena.com | Miranda McLaren

    Global immunization programs have successfully eradicated or controlled many infectious diseases throughout history. However, challenges like antimicrobial resistance, climate change, and the potential threat of biological warfare are continuously reshaping the global health landscape. As these factors evolve, new pathogens or mutated strains of existing ones may emerge.

  • 2 weeks ago | clinicaltrialsarena.com | Miranda McLaren

    May 2025 – London & Boston – Perceptive eClinical unveils ClinPhone Pro, a next-generation RTSM platform. Built on over 30 years of experience, ClinPhone Pro integrates seamlessly within the clinical technology ecosystem, offering advanced drug supply simulation and rolling forecast capabilities. This enables sponsors and CROs to plan smarter and run more sustainable trials without adding operational burden.

  • 3 weeks ago | businessandamerica.com | Miranda McLaren

    Europe has witnessed strong growth in orphan drug approvals over the past decade, yet for pharmaceutical innovators, securing market access for these rare disease therapies remains challenging without the right support. Dozens of new orphan medicines are reaching the market each year under the incentives of the EU Orphan Medicinal Products Regulation, which since 2000 has spurred more than 192 orphan drug approvals through 2022.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →